AMPLIFY-7P Phase 2 randomized study anticipated to complete enrollment in Q4 2024; formal interim analysis of disease-free survival ("DFS") expected in H1 2025Poster presentation at the Society for Im ...

In August 2024, Elicio received a $1.5M grant from the Gastro-Intestinal Research Foundation to support continued development of vaccines targeting p53 and BRAF mutations. In July 2024, a $11.5M ...

EGFR Mutation Testing on Cytological and Histological Samples in ... Clinical impact of TROP2 in non-small lung cancers and its correlation with abnormal p53 nuclear accumulation. Pathol Int.

In a report released yesterday, Jason McCarthy from Maxim Group maintained a Buy rating on Aprea Therapeutics (APRE – Research Report), ...

Researchers at the National Institutes of Health (NIH) and their collaborators have discovered a new way in which RAS genes, ...

Mutation or dysregulation of tumour-suppressor proteins can lead to unregulated cell growth and tumour development. A review summarizes the recent advances in ferroptosis and tumor suppression ...

POLK expression in neurons and report an important observation that POLK exhibits an age-dependent change in subcellular localization, from the nucleus in young tissue to the cytoplasm in old tissue.

Nov. 11, 2024 — A team of scientists has used a novel approach to identify protein degraders that target Pin1, a protein involved in pancreatic cancer ... DNA Packaging Directly Affects How Fast ...

Their findings pave the ... Cancer Risk Linked to P53 in Ulcerative Colitis Oct. 25, 2024 — Researchers have elucidated the role of the p53 gene in ulcerative colitis. The study suggests a ...